ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2021

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis.

Jane R Schwebke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.